“…(Hoogman et al, 2017, p. 311) It remains important to stress that this assertion was found to be incorrect for the general population with respect to other mental disorders such as schizophrenia or depression, where biological illness concepts were generally associated with more rather than less stigma (Angermeyer, Holzinger, Carta, & Schomerus, 2011;Kvaale, Gottdiener, & Haslam, 2013;Schomerus, Matschinger, & Angermeyer, 2014;Speerforck, Schomerus, Pruess, & Angermeyer, 2014). Also, issues with methodological limitations and the heterogenic etiology of ADHD were raised in reply to that mega-analysis (Batstra et al, 2017;Dehue et al, 2017). Furthermore, evidence for treatments with stimulants such as methylphenidate was subject to intensive academic debate: Whereas a Cochrane Review on methylphenidate for children and adolescents concluded that "the low quality of the underpinning evidence means that we cannot be certain of the magnitude of the effects" (Storebø et al, 2015), other researchers repeatedly criticized this main conclusion (e.g., Gerlach et al, 2017;Romanos, Coghill et al, 2016;Romanos, Reif, & Banaschewski, 2016).…”